Lin D N, Li Q L, He X J, Li H, Liao L B, He H, Zhou L L, Li Z, Liu X L, Liu Q F, Zhou H S, Cao R
Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Department of Hematology, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530000, China.
Zhonghua Xue Ye Xue Za Zhi. 2020 Sep 14;41(9):749-755. doi: 10.3760/cma.j.issn.0253-2727.2020.09.008.
To establish a screening system of adult Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) by fluorescence in situ hybridization (FISH) . Based on the genetic characteristics of Ph-like ALL, FISH probes were designed for ABL1, ABL2, JAK2, EPOR, CRLF2, CSF1R, PDGFRB, and P2RY8 gene breakpoints, which were used to screen Ph-like ALL in B-ALL patients without BCR-ABL1, ETV6-RUNX1, MLL, and E2A gene arrangement. Furthermore, it was analyzed in combination with flow immunophenotype, next-generation sequencing for targeted gene mutations, and RNA sequencing (RNA-seq) . A total of 189 adult B-ALL patients diagnosed in Nanfang Hospital from January 2016 to April 2019 were enrolled in this study. Using FISH and/or PCR, BCR-ABL1, ETV6-RUNX1, MLL, or E2A arrangement was detected in 83 of them, and Ph-like ALL was detected by FISH in the other 106, resulting in the presence of typical gene arrangements of Ph-like ALL in 12 patients (11.3% , 12/106) . Validated by RNA-seq, the sensitivity and specificity of FISH for Ph-like ALL were 71.4% and 95.8% , respectively. After further analysis with immunophenotype, targeted gene mutations, and RNA-seq, 14 (13.2% , 14/106) were diagnosed with Ph-like ALL. This data shows high specificity of FISH for identification of Ph-like ALL and combining immunophenotype and sequencing technology can improve the diagnostic system.
通过荧光原位杂交(FISH)建立成人费城染色体样急性淋巴细胞白血病(Ph样ALL)筛查系统。基于Ph样ALL的遗传特征,设计了用于ABL1、ABL2、JAK2、EPOR、CRLF2、CSF1R、PDGFRB和P2RY8基因断点的FISH探针,用于筛查无BCR-ABL1、ETV6-RUNX1、MLL和E2A基因重排的B-ALL患者中的Ph样ALL。此外,结合流式免疫表型、靶向基因突变的二代测序和RNA测序(RNA-seq)进行分析。本研究纳入了2016年1月至2019年4月在南方医院诊断的189例成人B-ALL患者。使用FISH和/或PCR检测其中83例患者存在BCR-ABL1、ETV6-RUNX1、MLL或E2A重排,另外106例通过FISH检测到Ph样ALL,其中12例(11.3%,12/106)存在Ph样ALL的典型基因重排。经RNA-seq验证,FISH检测Ph样ALL的灵敏度和特异性分别为71.4%和95.8%。经免疫表型、靶向基因突变和RNA-seq进一步分析后,14例(13.2%,14/106)被诊断为Ph样ALL。该数据表明FISH对Ph样ALL的识别具有高特异性,结合免疫表型和测序技术可改善诊断系统。